Results 161 to 170 of about 21,848 (263)

Effectiveness of antenatal care delivery of intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine in the context of an integrated strategy with seasonal malaria chemoprevention in Mali and Burkina Faso. [PDF]

BMJ Glob Health
Koita K, Kayentao K, Worrall E, Huyen Ton Nu Nguyet M, Coulibaly O, Bognini JD, Tinto H, Rouamba T, Dembele M, Biébo B, Diarra S, Briand V, Hill J.   +12 more
europepmc   +1 more source

Impact of Sulfadoxine-Pyrimethamine Resistance on Effectiveness of Intermittent Preventive Therapy for Malaria in Pregnancy at Clearing Infections and Preventing Low Birth Weight.

Clinical Infectious Diseases, 2016
M. Desai, J. Gutman, S. Taylor, R. Wiegand, Carole Khairallah, K. Kayentao, P. Ouma, S. O. Coulibaly, Linda Kalilani, K. Mace, E. Arinaitwe, D. Mathanga, O. Doumbo, K. Otieno, D. Edgar, E. Chaluluka, Mulakwa Kamuliwo, V. Ades, J. Skarbinski, Y. Shi, P. Magnussen, S. Meshnick, F. T. ter Kuile   +22 more
semanticscholar   +1 more source

Inequalities in the use of three-dose of intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine among women in Sierra Leone, 2008-2019. [PDF]

Malar J
Osborne A, Bai-Sesay AU, Sesay U, Bangura C, Ahinkorah BO.   +4 more
europepmc   +1 more source

Impact of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine on sexually transmitted and reproductive tract infections: results from a randomized trial in Uganda. [PDF]

Int J Epidemiol
Adrama H, Dela Cruz EJ, Ozarslan N, Kakuru A, Odongo B, Gaw SL, Benjamin-Chung J, Kizza J, Aguti M, Ategeka J, Olwoch P, Nakalembe M, Opira B, Clark TD, Kamya MR, Rosenthal PJ, Dorsey G, Roh ME.   +17 more
europepmc   +1 more source

Prevalence of antimalarial drug resistance molecular markers in Makenene, central Cameroon. [PDF]

Int J Parasitol Drugs Drug Resist
Kala-Chouakeu NA, Djoufounna J, Benoit N, Tchuinkam T, Delandre O, Almeras L, Bamou R, Antonio-Nkondjio C, Madamet M, Pradines B.   +9 more
europepmc   +1 more source

Trends in Plasmodium falciparum resistance markers to sulfadoxine-pyrimethamine and amodiaquine over ten years of seasonal malaria chemoprevention in Moissala Health District, Chad. [PDF]

Malar J
Grandesso F, Diar MSI, Kouassi F, Sayyad-Hilario J, Ouedraogo P, Djimde AA, Singh S, Dama S.   +7 more
europepmc   +1 more source

Comparative effects of antimalarial drugs on oxidative phosphorylation, mitochondrial dynamics and mitophagy in <i>Plasmodium berghei</i>-infected mice. [PDF]

Toxicol Rep
Olanlokun JO, Yahaya OO, Babarinde CO, Oloke OM, Steenkamp P, Prinsloo G.   +5 more
europepmc   +1 more source

Pyrimethamine-Sulfadoxine [PDF]

, 2020
openaire   +1 more source

The impact of sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive treatment for the prevention of malaria in pregnancy in Africa: an updated systematic review and meta-analysis. [PDF]

Lancet Infect Dis
van Eijk AM, Stepniewska K, Khairallah C, Rodriguez E, Ahn J, Gutman JR, Ter Kuile FO, IPTp-SP Effectiveness Study group.   +7 more
europepmc   +1 more source

Parasite clearance and protection from Plasmodium falciparum infection (PCPI): a two-arm, parallel, double-blinded, placebo-controlled, randomised trial of presumptive sulfadoxine-pyrimethamine versus artesunate monotherapy among asymptomatic children 3-5 years of age in Zambia. [PDF]

BMC Infect Dis
Martinez-Vega R, Chaponda M, Mousa A, Gwasupika J, Chaponda EB, Daka V, Mwanza S, Chipunga M, Beshir KB, Chopo-Pizarro A, Kaur H, Okell L, Hansson H, Hocke EF, Alifrangis M, Gosling R, Roper C, Sutherland C, Chico RM.   +18 more
europepmc   +1 more source